Nordic Mubio

What Nordic Mubio does

Nordic-MUbio (legal entity: Nordic Immunological Laboratories BV) develops and manufactures high-quality antibody reagents for biomedical research and pharmaceutical R&D, operating from Susteren, Netherlands under ISO 9001:2023-certified quality management. The portfolio aggregates 2,961+ products across primary and secondary antibodies, proteins, kits, and cell biology reagents, organized around five core brands: Nordic (1,700+ antisera to immunoglobulin classes, established 1964), MUbio (500+ monoclonal antibodies targeting cytoskeletal and adhesion proteins, spun out of Maastricht University in 2000), FIX&PERM (proprietary CE/IVD-registered cell fixation/permeabilization kit for flow cytometry), BrdUKits (cell proliferation assays), and the acquired Biologo (AGE/extracellular matrix antibodies) and Scicons (anti-dsRNA J2 monoclonal antibody line, gold standard with 200+ publications). The technology foundation combines hybridoma-based antibody production with extensive multi-application validation: 80%+ antibodies tested in immunohistochemistry on frozen tissues, 70% in flow cytometry, and 50%+ in Western Blot, supported by comprehensive product-specific scientific data, images, and literature references.

The business operates a hybrid revenue model comprising one-time catalog antibody/reagent sales, custom assay development and antibody production services, and partnered diagnostic application development in lung and other cancers. Go-to-market is primarily distributor-led through a selected network of regional partners and OEM relationships spanning 50+ countries across Europe, the Americas, Asia Pacific, Africa, and the Middle East, with inventory held in Susteren for rapid European fulfilment and direct enterprise engagement for large pharma/biotech bulk orders and custom projects. End customers span academic and research institutions, pharmaceutical and biotechnology companies, veterinary researchers, and the zebrafish research community, where Nordic-MUbio is one of the leading providers with 50+ validated antibodies. Since 2013 the company has executed six acquisitions (MUbio, ADG, Brighter Ideas/GFP, Biologo, Gallus via Exalpha, SCICONS) and in October 2022 became a brand under Absolute Biotech, a multi-brand antibody aggregator combining Nordic-MUbio with Absolute Antibody, LSBio, Kerafast, Everest Biotech, and Exalpha. Leadership comprises CEO Ronald Rutten, CSO Prof. Dr. Frans Ramaekers, and Sales and Marketing Director Tim Bernard.

Name

Nordic Mubio

Legal name

Nordic Immunological Laboratories BV

Website

https://nordicmubio.com

Company type

Private

Founded year

1964

Operating status

Operating

Headcount range

11–50 employees

Short description

Nordic-MUbio develops and manufactures validated antibody reagents for biomedical research, offering 2,961+ products including monoclonal and polyclonal antibodies, flow cytometry kits, and diagnostic candidates across catalog and custom service lines. It serves academic, pharmaceutical, and biotechnology researchers globally via a 50+ country distributor network, operating as a brand under Absolute Biotech.

Ownership category

akta.pro rank

Product category

Research Antibodies

NAICS

Biological Product (except Diagnostic) Manufacturing (325414), In-Vitro Diagnostic Substance Manufacturing (325413)

SIC

Biological Products, (No Disgnostic Substances) (2836), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)

akta.pro secondary industries

Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering) (HLAAAIAB), Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL)

Keywords

• Research antibody reagents
• Monoclonal antibody manufacturing
• Flow cytometry reagents
• Immunohistochemistry antibodies
• Life science diagnostics

Headquarters

HQ city

Susteren

HQ country

Netherlands

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations

Revenue model

1. Antibody and Reagent Product Sales: Sale of research antibody reagents including monoclonal and polyclonal antibodies, conjugated antibodies (FITC, PE, HRP, biotin), antisera, proteins, control antibodies, and assay kits. Products are sold through distributors worldwide and directly to large customers.
2. Custom Services: Assay development and custom antibody production services offered to pharmaceutical and biotech customers.
3. Diagnostic Applications Development: Proprietary and partnered development programs investigating, testing and validating patented antibodies and antigens for diagnostic applications in lung and other cancers.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels2 records

Core offering

Nordic-MUbio develops and manufactures high-quality antibody reagents for biomedical R&D, with a portfolio of over 2,961 catalog products including monoclonal and polyclonal primary antibodies, conjugated secondary antibodies (FITC, PE, HRP, biotin), proteins/peptides, control antibodies, and assay kits. The company focuses on antibodies targeting cell adhesion, nuclear, and cytoskeletal proteins, with deep specialization in zebrafish research and validated applications across immunohistochemistry, flow cytometry, Western Blot, ELISA, and immunofluorescence. Core proprietary offerings include the FIX&PERM Cell Fixation and Permeabilization Kit (CE/IVD registered for clinical labs), BrdU Cell Proliferation Assay Kits, and the J2/K1/K2 anti-dsRNA monoclonal antibody franchise.

Product overview

Nordic-MUbio is a research reagent company that develops and manufactures high-quality antibody reagents for biomedical research. The company operates as a unified portfolio of multiple acquired and developed brands under Absolute Biotech, offering over 2,961 products including primary antibodies, secondary antibodies, assay kits, and cell biology reagents. The core brands include Nordic (established 1964, specializing in antisera to immunoglobulins), MUbio (spun out of Maastricht University 2000, focusing on cytoskeletal and adhesion proteins), FIX&PERM® Cell Fixation and Permeabilization Kit (acquired 2013 from An Der Grub Bio Research, essential for flow cytometry intracellular staining), BrdUKits (cell proliferation assay kits), Biologo (acquired 2018, advanced glycation end-products and extracellular matrix antibodies), and Scicons (acquired 2021, anti-dsRNA monoclonal antibodies for viral detection). Nordic-MUbio also distributes products from affiliated brands including Exalpha and Gallus. The company focuses on antibodies targeting cell adhesion, nuclear and cytoskeletal proteins, with particular expertise in zebrafish research and flow cytometry applications. All products are manufactured according to ISO 9001 quality guidelines.

Differentiator

Problem solved

Functional benefit

Brands

• Biologo: Monoclonal and polyclonal antibodies for advanced glycation end-products (AGE), extracellular matrix proteins, and cancer research markers. Acquired in 2018.
• BrdUKits
• FIX&PERM
• MUbio
• Nordic
• Scicons

Products and services

• FIX&PERM Cell Fixation and Permeabilization Kit

Quantifiable outcome

• Over 80% of antibodies tested in immunohistochemistry on frozen tissues
• +2 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Four partnerships are on record, tiered core and minor.

• Absolute BiotechcoreStrategic or Co-development Partner · 4 October 2022Nordic-MUbio became a brand under Absolute Biotech, a unified company joining multiple antibody-centric brands. Absolute Biotech specializes in antibody reagents and services, offering customers worldwide the full breadth of antibody-related products, services and expertise. Nordic-MUbio continues operating as a brand within the Absolute Biotech family.
• Maastricht UniversitycoreStrategic or Co-development PartnerMUbio was spun out of Maastricht University in the Netherlands in 2000, giving rise to its name. Ongoing academic partnerships select new markers and extend product range through contact with different international universities and research groups.
• Academic and Research InstitutionsminorStrategic or Co-development PartnerNordic-MUbio is continuously in close contact with different academic institutions and research groups to select additional opportunities for licensing products and extending product range of antibodies and diagnostic applications.
• Global Distributor NetworkcoreChannel Partner/ Reseller/ DistributorNordic-MUbio distributes products worldwide through a selected network of distributors. These include regional distributors across Europe, Americas, Asia, Africa, and Oceania such as Bio-Connect (Benelux), Nordic BioSite (Scandinavia), CliniSciences (Western Europe), 2B Scientific (UK/Germany), Exalpha Biologicals (USA), Cosmo Bio (Japan), and many others covering 50+ countries.

Scale indicators10 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Rockland Immunochemicals: Rockland Immunochemicals manufactures antibodies and antibody-based reagents for life science research, with a focus on secondary antibodies and conjugates overlapping with Nordic-MUbio's Nordic-branded secondary antibody catalogue serving the same research end users.
• Cell Signaling Technology: CST is a leading US-based antibody reagent company specialising in validated antibodies for Western Blot, IHC, flow cytometry, and ELISA — the same application matrix Nordic-MUbio competes in, with the same academic and pharma research customer base.
• Abcam: Abcam is the global category leader in research-use antibodies, serving academic and pharma R&D labs with deep catalogues, validated data, and direct distribution — directly comparable in target customer, product type, and channel as Nordic-MUbio's primary competition for orders from the same researcher buyer.
• GeneTex: GeneTex is an antibody reagent company focused on validated research antibodies for cancer, cell biology, and immunology — directly comparable in product category, customer base (academic/clinical research), and distribution model to Nordic-MUbio.
• Atlas Antibodies: Atlas Antibodies is a Swedish research antibody company (now part of the same Sigma-Aldrich/Merck ecosystem's neighbouring niche) producing highly validated monoclonal antibodies for IHC and neuroscience — a close-scale, Scandinavian-rooted analogue to Nordic-MUbio with similar academic spin-out heritage and validation-driven positioning.
• Santa Cruz Biotechnology: Santa Cruz Biotechnology is a long-established broad-line antibody reagent supplier targeting the same academic and biomedical research market as Nordic-MUbio, with overlapping focus on monoclonal and polyclonal antibodies and similar distributor-mediated global reach.

Broad incumbents

• Thermo Fisher Scientific: Thermo Fisher owns the Invitrogen, Pierce, and Thermo Scientific antibody reagent lines that compete head-to-head with Nordic-MUbio's primary and secondary antibody catalogue across all major applications (IHC, Western Blot, flow cytometry).
• Bio-Rad Laboratories: Bio-Rad operates a substantial life science research reagents and antibodies business (the former AbD Serotec) and broad clinical diagnostics portfolio — a larger incumbent in the same research-use antibody category, competing for the same flow cytometry and immunology budgets as Nordic-MUbio.

Emerging players

• Proteintech Group: Proteintech is a rapidly growing mid-market antibody reagent manufacturer that has expanded from niche origins into a global catalogue competitor — comparable as a direct research-antibody peer but at a different growth and scale phase than Nordic-MUbio.
• BD Biosciences: BD Biosciences is a major flow cytometry reagent and antibody supplier that overlaps directly with Nordic-MUbio's FIX&PERM-centred flow cytometry business, competing for the same clinical and research flow cytometry antibody spend.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nordic Mubio